Helderman J H, Strom T B
J Clin Invest. 1977 Feb;59(2):338-44. doi: 10.1172/JCI108646.
Insulin, as well as other ligands which increase intracellular guanosine 3',5'-cyclic monophosphate (cGMP), augments thymic-derived (T)- lymphocyte effector activity as revealed by alloimmune lymphocyte-mediated cytotoxicity. The observation that insulin binds only to monocytes among circulating nonimmune human mononuclear cells fosterd reexamination of the mechanism by which insulin augments T-lymphocyte function. This report concerns a test of the hypothesis that the T cell is directly affected by insulin and that an insulin receptor emerges upon T lymphocytes consequent to immune activation. Spleens were removed from rats skin grafted across a major histocompatibility barrier. Lymphocytes were harvested from Ficoll-Hypaque density gradients and subsequently enriched for T cells by passage over one or two nylon wool columns. This population was composed of more than 98% T cells as assessed by surface marker techniques (Ig staining, erythrocyte antibody, and erythrocyte antibody complement rosetting, anti-T staining). There was no loss of augmentation of lymphocyte-mediated cytotoxicity induced by insulin, carbamycholine, and 8-bromo-cGMP in the purified cells when compared to unfractionated cells 7 days after transplantation. 125I-insulin bound saturably to the allostimulated T-enriched lymphocytes with maximum binding at 12.8 +/- 0.2 pg and a dissociation constant at equilibrium of 1.3 nM. In contrast, insulin receptors were not present on nonimmune T-enriched cells or on T cells from animals that received syngeneic grafts. The affinity of the lymphocyte insulin receptor was similar to that of more conventional insulin-sensitive tissues e.g., liver, adipocyte. After 89% of T cells from spleens on day 7 were lysed with anti-thy 1.1 antibody and complement, the ability to measure specific insulin binding was lost. These data confirm a physiologic role for insulin in T-lymphocyte effector function and describe the emergence of insulin receptors concomitant with cell sensitivity to ligand. Such receptors may play a role in hormonal modulation of the immune response.
胰岛素以及其他能增加细胞内鸟苷 3',5'-环磷酸(cGMP)的配体,可增强胸腺来源(T)淋巴细胞的效应活性,这在同种异体免疫淋巴细胞介导的细胞毒性中得以体现。胰岛素仅与循环中的非免疫人单核细胞中的单核细胞结合,这一观察结果促使人们重新审视胰岛素增强 T 淋巴细胞功能的机制。本报告涉及对以下假设的检验:T 细胞直接受胰岛素影响,并且在免疫激活后 T 淋巴细胞上会出现胰岛素受体。从跨越主要组织相容性屏障进行皮肤移植的大鼠身上取出脾脏。从 Ficoll-Hypaque 密度梯度中收获淋巴细胞,随后通过在一两个尼龙毛柱上通过来富集 T 细胞。通过表面标记技术(Ig 染色、红细胞抗体和红细胞抗体补体花环形成、抗 T 染色)评估,该群体中 T 细胞占比超过 98%。与未分离的细胞相比,移植 7 天后,纯化细胞中胰岛素、卡巴胆碱和 8-溴-cGMP 诱导的淋巴细胞介导的细胞毒性增强作用并未丧失。125I-胰岛素与同种异体刺激的富含 T 细胞的淋巴细胞饱和结合,最大结合量为 12.8±0.2 pg,平衡解离常数为 1.3 nM。相比之下,非免疫的富含 T 细胞的细胞或接受同基因移植动物的 T 细胞上不存在胰岛素受体。淋巴细胞胰岛素受体的亲和力与更传统的胰岛素敏感组织(如肝脏、脂肪细胞)相似。在第 7 天,用抗 Thy 1.1 抗体和补体裂解脾脏中 89%的 T 细胞后,测量特异性胰岛素结合的能力丧失。这些数据证实了胰岛素在 T 淋巴细胞效应功能中的生理作用,并描述了胰岛素受体与细胞对配体敏感性同时出现的情况。此类受体可能在免疫反应的激素调节中发挥作用。